Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ).
Guangdong Kanghua Healthcare Group Co., Ltd. reported its interim results for the six months ending June 30, 2025, showing a slight revenue decrease of 0.3% to RMB981.5 million compared to the same period in 2024. Despite the revenue dip, the company turned around its financial performance with a profit of RMB32.6 million, a significant improvement from a loss of RMB24.7 million in the previous year. The adjusted EBITDA saw a notable increase of 38.7% to RMB126.7 million, reflecting improved operational efficiency. However, the Board decided not to recommend an interim dividend for this period.
The most recent analyst rating on (HK:3689) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the healthcare industry. The company is involved in providing healthcare services, with a focus on delivering medical and healthcare solutions to its clients.
Average Trading Volume: 38,535
Technical Sentiment Signal: Hold
Current Market Cap: HK$665.4M
See more data about 3689 stock on TipRanks’ Stock Analysis page.